A pharmaceutical company announced positive results Monday for an investigational oral medication designed to treat a specific form of blood pressure condition.
United Therapeutics reported that their experimental drug successfully achieved all primary and secondary endpoints in advanced-stage clinical testing. The oral treatment is being developed as a potential therapy for patients suffering from a particular type of blood pressure disorder.
The announcement on Monday highlighted the completion of late-phase study objectives for the investigational medication, marking a significant milestone in the drug’s development process.
